These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 7803507
1. Calpain-induced down-regulation of protein kinase C inhibits dense-granule secretion in human platelets. Inhibition of platelet aggregation or calpain activity preserves protein kinase C and restores full secretion. Patel Y, Kakkar VV, Authi KS. Biochim Biophys Acta; 1994 Dec 30; 1224(3):480-8. PubMed ID: 7803507 [Abstract] [Full Text] [Related]
2. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation. Krishnamurthi S, Dickens TA, Patel Y, Wheeler-Jones CP, Kakkar VV. Biochem Biophys Res Commun; 1989 Sep 29; 163(3):1256-64. PubMed ID: 2783136 [Abstract] [Full Text] [Related]
3. Suppression by wortmannin of platelet responses to stimuli due to inhibition of pleckstrin phosphorylation. Yatomi Y, Hazeki O, Kume S, Ui M. Biochem J; 1992 Aug 01; 285 ( Pt 3)(Pt 3):745-51. PubMed ID: 1497612 [Abstract] [Full Text] [Related]
4. Protein kinase C-dependent and Ca2+-dependent mechanisms of secretion from streptolysin O-permeabilized platelets: effects of leakage of cytosolic proteins. Sloan DC, Haslam RJ. Biochem J; 1997 Nov 15; 328 ( Pt 1)(Pt 1):13-21. PubMed ID: 9359828 [Abstract] [Full Text] [Related]
5. Phorbol 12-myristate 13-acetate-stimulated phosphorylation of erythrocyte membrane skeletal proteins is blocked by calpain inhibitors: possible role of protein kinase M. Al Z, Cohen CM. Biochem J; 1993 Dec 15; 296 ( Pt 3)(Pt 3):675-83. PubMed ID: 8280066 [Abstract] [Full Text] [Related]
6. Receptor- and phorbol-ester-mediated redistribution of protein kinase C in human platelets. Evidence that aggregation promotes degradation of protein kinase C. Wheeler-Jones CP, Patel Y, Kakkar VV, Krishnamurthi S. Biochem J; 1989 Nov 01; 263(3):969-72. PubMed ID: 2597139 [Abstract] [Full Text] [Related]
7. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies. Krishnamurthi S, Patel Y, Kakkar VV. Biochim Biophys Acta; 1989 Feb 09; 1010(2):258-64. PubMed ID: 2492201 [Abstract] [Full Text] [Related]
8. The antioxidant butylated hydroxytoluene (BHT) inhibits the dioctanoylglycerol-evoked platelet response but potentiates that elicited by ionomycin. Ruzzene M, Francesconi M, Donella-Deana A, Alexandre A, Deana R. Arch Biochem Biophys; 1992 May 01; 294(2):724-30. PubMed ID: 1314548 [Abstract] [Full Text] [Related]
10. Synthesis of intracellular histamine in platelets is associated with activation of protein kinase C, but not with mobilization of Ca2+. Saxena SP, Robertson C, Becker AB, Gerrard JM. Biochem J; 1991 Jan 15; 273(Pt 2)(Pt 2):405-8. PubMed ID: 1899334 [Abstract] [Full Text] [Related]
18. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. Lockhart LK, McNicol A. J Pharmacol Exp Ther; 1999 May 15; 289(2):721-8. PubMed ID: 10215645 [Abstract] [Full Text] [Related]
19. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. Miyakawa Y, Oda A, Druker BJ, Ozaki K, Handa M, Ohashi H, Ikeda Y. Blood; 1997 Apr 15; 89(8):2789-98. PubMed ID: 9108397 [Abstract] [Full Text] [Related]
20. Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. Murphy CT, Westwick J. Biochem J; 1992 Apr 01; 283 ( Pt 1)(Pt 1):159-64. PubMed ID: 1567363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]